Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D D Ross

Showing results (21-30 of 69) with videos related to

Pageof 7
Sort By:
Cytometry|March 1, 1989
Improvement of flow-cytometric detection of multidrug-resistant cells by cell-volume normalization of intracellular daunorubicin contentD D Ross, B W Thompson, J V Ordóñez, et al.
Biochemical Pharmacology|November 9, 1995
Susceptibility of idarubicin, daunorubicin, and their C-13 alcohol metabolites to transport-mediated multidrug resistanceD D Ross, L A Doyle, W Yang, et al.
Cancer|November 1, 1979
Loss of terminal deoxynucleotidyl transferase (TdT) activity as a predictor of emergence of resistance to chemotherapy in a case of chronic myelogenous leukemia in blast crisisD D Ross, P H Wiernik, P S Sarin, et al.
Cancer Research|November 1, 1981
Effects of deoxynucleosides on cultured human leukemia cell growth and deoxynucleotide poolsD D Ross, S A Akman, A W Schrecker, et al.
Biochimica Et Biophysica Acta|August 2, 1983
Persistence of herpes simplex virus type-2 genome in a human leukemic cell lineN Biswal, U Ko, S Akman, et al.
Cancer Research|July 1, 1996
H19 gene overexpression in atypical multidrug-resistant cells associated with expression of a 95-kilodalton membrane glycoproteinL A Doyle, W Yang, A K Rishi, et al.
Journal of Surgical Oncology|February 1, 1989
Killing lung cancer cells at cell-cycle phase by a new indium-111-bleomycin complexD Y Hou, J V Ordonez, R J Cross, et al.
Journal of Bioenergetics and Biomembranes|January 24, 2002
The role of half-transporters in multidrug resistanceS E Bates, R Robey, K Miyake, et al.
Cancer Research|January 4, 1998
The 95-kilodalton membrane glycoprotein overexpressed in novel multidrug-resistant breast cancer cells is NCA, the nonspecific cross-reacting antigen of carcinoembryonic antigenD D Ross, Y Gao, W Yang, et al.
Cancer Research|January 26, 2000
Fumitremorgin C reverses multidrug resistance in cells transfected with the breast cancer resistance proteinS K Rabindran, D D Ross, L A Doyle, et al.
Pageof 7

Showing results (21-30 of 69) with videos related to

Sort By:
Pageof 7
Cytometry|March 1, 1989
Improvement of flow-cytometric detection of multidrug-resistant cells by cell-volume normalization of intracellular daunorubicin contentD D Ross, B W Thompson, J V Ordóñez, et al.
Biochemical Pharmacology|November 9, 1995
Susceptibility of idarubicin, daunorubicin, and their C-13 alcohol metabolites to transport-mediated multidrug resistanceD D Ross, L A Doyle, W Yang, et al.
Cancer|November 1, 1979
Loss of terminal deoxynucleotidyl transferase (TdT) activity as a predictor of emergence of resistance to chemotherapy in a case of chronic myelogenous leukemia in blast crisisD D Ross, P H Wiernik, P S Sarin, et al.
Cancer Research|November 1, 1981
Effects of deoxynucleosides on cultured human leukemia cell growth and deoxynucleotide poolsD D Ross, S A Akman, A W Schrecker, et al.
Biochimica Et Biophysica Acta|August 2, 1983
Persistence of herpes simplex virus type-2 genome in a human leukemic cell lineN Biswal, U Ko, S Akman, et al.
Cancer Research|July 1, 1996
H19 gene overexpression in atypical multidrug-resistant cells associated with expression of a 95-kilodalton membrane glycoproteinL A Doyle, W Yang, A K Rishi, et al.
Journal of Surgical Oncology|February 1, 1989
Killing lung cancer cells at cell-cycle phase by a new indium-111-bleomycin complexD Y Hou, J V Ordonez, R J Cross, et al.
Journal of Bioenergetics and Biomembranes|January 24, 2002
The role of half-transporters in multidrug resistanceS E Bates, R Robey, K Miyake, et al.
Cancer Research|January 4, 1998
The 95-kilodalton membrane glycoprotein overexpressed in novel multidrug-resistant breast cancer cells is NCA, the nonspecific cross-reacting antigen of carcinoembryonic antigenD D Ross, Y Gao, W Yang, et al.
Cancer Research|January 26, 2000
Fumitremorgin C reverses multidrug resistance in cells transfected with the breast cancer resistance proteinS K Rabindran, D D Ross, L A Doyle, et al.
Pageof 7